Prevalence, Awareness, Treatment, and Control of Hypertension among Kazakhs with high Salt Intake in Xinjiang, China: A Community-based Cross-sectional Study

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Hu, Yaoda ^a   Wang, Zixing ^a   Wang, Yuyan ^a   Wang, Lei ^a   Han, Wei ^a   Tang, Yong ^b   Xue, Fang ^a   Hou, Lei ^a   Liang, Shaohua ^b   Zhang, Biao ^a   Wang, Weizhi ^b   Asaiti, Kuliqian ^c   Pang, Haiyu ^a   Zhang, Mingtao ^a,b   Jiang, Jingmei ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b People's Hospital of Altay Prefecture   (China)

^c Hong Dun Town Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ATTITUDE TO HEALTH; CHINA; CROSS-SECTIONAL STUDY; ETHNOLOGY; FEMALE; HUMAN; HYPERTENSION; KAZAKHSTAN; MALE; MIDDLE AGED; PREVALENCE; SALT INTAKE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; KAZAKHSTAN; MALE; MIDDLE AGED; PREVALENCE; SODIUM CHLORIDE, DIETARY;

EID: 85016576604     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep45547     Document Type: Article

References (31)

1. Naish, J., Revest, P. & Court, D. S. Medical sciences. (Naish, Jeannette, 2009).
2. World Health Organization. A global brief on hypertension: Silent killer, global public health crisis. http://www.who.int/ cardiovascular-diseases/publications/global-brief-hypertension/en/ (Date of access: 11/02/2017) (2013).
3. Lim, S. S. et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 380, 2224-2260 (2012).
4. World Health Organization. Global status report on noncommunicable diseases 2014. (World Health Organization, 2014).
5. Li, W. et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China. J Hypertens. 34, 39-46 (2016).
6. Writing Group of 2010 Chinese Guidelines for the Management of Hypertension.2010 Chinese guidelines for the management of hypertension. Chin J Cardiol. 39, 579-616 (2011).
7. Turnbull, F. et al. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectivelydesigned overviews of randomised trials. Lancet. 362, 1527-1535 (2003).
8. Neal, B. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet. 356, 1955-1964 (2000).
9. Guo, J. et al. Status of prevalence, awareness, treatment and controll on hypertension among adults in 10 regions, China. Chin J Epidemiol. 37, 469-474 (2016).
10. Hozawa, A. & Ueshima, H. Blood pressure differences by race: the importance of assessing lifestyle. Hypertens Res. 32, 1049-50 (2009).
11. Subasinghe, A. K. et al. Association between salt and hypertension in rural and urban populations of low to middle income countries: a systematic review and meta-analysis of population based studies. Asia Pac J Clin Nutr. 25, 402-413 (2016).
12. National Bureau of Statistics of China. The data of the fifth population census in China http://www.stats.gov.cn/tjsj/ndsj/ renkoupucha/2000pucha/pucha.htm (Date of access: 11/02/2017) (2000).
13. Wu, X. et al. Prevalence of hypertension and its trends in Chinese population. International Journal of Cardiology. 52, 39-44 (1995).
14. Liu, F. et al. Current status of primary hypertension in Xinjiang: an epidemiological study of Han, Uygur and Hazakh populations. Natl Med J China. 90, 3259-3263 (2010).
15. Jiang, J. et al. Prevalence of conventional cardiovascular disease risk factors among Chinese Kazakh individuals of diverse occupational backgrounds in Xinjiang China. Int J Cardiol. 179, 558-60 (2015).
16. Zhai, F. Y. et al. Status and characteristic of dietary intake of 12 minority nationalities in China. Journalof Hygiene Reasearch. 36, 539-541 (2007).
17. Wang, H. M. et al. Epidemiology Study on Hypertension of Kazakh in PastureArea of Fukang, Xinjiang. Chin J Hypertens. 18, 960-964 (2010).
18. Guan, X. M. et al. Analysis on hypertension prevalence among residents in Xinjiang monitoring stations, 2010. Chinese Journal of Health Education. 30, 971-975 (2014).
19. Jiang, B. et al. Hypertension Detection, Management, Control and Associated Factors Among Residents Accessing Community Health Services In Beijing. Sci Rep. 4, 4845 (2014).
20. Dong, F. et al. Disparities in Hypertension Prevalence, Awareness, Treatment and Control between Bouyei and Han: Results from a Bi-Ethnic Health Survey in Developing Regions from South China. Int J Environ Res Public Health. 13, 233 (2016).
21. Li, X. H., Qiao, Y., Li, B. J. & Li, C. X. Prevalence and awareness of hypertension in Gansu Gannan Tibetan adult population. Chin J Cardiol. 40, 527-529 (2012).
22. Wang, H. et al. Factors Associated with Prevalence, Awareness, Treatment and Control of Hypertension among Adults in Southern China: A Community-Based, Cross-Sectional Survey. PLoS One. 8, e62469 (2013).
23. Tonstad, S., Furu, K., Rosvold, E. O. & Skurtveit, S. Determinants of control of high blood pressure. The Oslo Health Study 2000-2001. Blood Press. 13, 343-349 (2004).
24. Czernichow, S. et al. Determinants of blood pressure treatment and control in obese people: evidence from the general population. J Hypertens. 30, 2338-2344 (2012).
25. Elliott, P., Stamler, J., Nichols, R., Dyer, A. R., Stamler, R., Kesteloot, H. et al. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. BMJ. 312, 1249-1253 (1996).
26. Khaw, K. T. et al. Blood pressure and urinary sodium in men and women: the Norfolk Cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk). Am J Clin Nutr. 80, 1397-1403 (2004).
27. O'Donnell, M. et al. PURE Investigators. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 371, 612-623 (2014).
28. Tanaka, T. et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 16, 97-103 (2002).
29. Hou, L. et al. Influence of Salt Intake on Association of Blood Uric Acid with Hypertension and Related Cardiovascular Risk. Plos One. 11, e0150451 (2016).
30. Cooperative Meta-analysis Group of China Obesity Task Force. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. China J Epidemiol. 23, 5-10 (2002).
31. Kawano, Y. et al. Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension. Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension: (2) Assessment of salt intake in the management of hypertension. Hypertens Res. 30, 887-893 (2007).